Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-008424
Filing Date
2024-05-17
Accepted
2024-05-17 16:43:17
Documents
3
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240626xdef14a.htm DEF 14A 346149
2 GRAPHIC tmb-20240626xdef14a_bg001.jpg GRAPHIC 126097
3 GRAPHIC tmb-20240626xdef14a_bg002.jpg GRAPHIC 179220
  Complete submission text file 0001558370-24-008424.txt   768063
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39619 | Film No.: 24960588
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)